# Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome

> **NCT00199446** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin, Inc.** · enrollment: 160 (—)

## Conditions studied

- Sleep Disorder
- Restless Legs Syndrome

## Interventions

- **DRUG:** Istradefylline (KW-6002)

## Key facts

- **NCT ID:** NCT00199446
- **Lead sponsor:** Kyowa Kirin, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-08
- **Final completion:** 2006-10
- **Target enrollment:** 160 (—)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00199446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00199446, "Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00199446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*